Novartis Ag (NVS) Goodwill (2016 - 2025)
Historic Goodwill for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $25.6 billion.
- Novartis Ag's Goodwill rose 327.6% to $25.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.6 billion, marking a year-over-year increase of 327.6%. This contributed to the annual value of $25.6 billion for FY2025, which is 327.6% up from last year.
- According to the latest figures from Q4 2025, Novartis Ag's Goodwill is $25.6 billion, which was up 327.6% from $25.6 billion recorded in Q3 2025.
- Novartis Ag's 5-year Goodwill high stood at $29.8 billion for Q2 2021, and its period low was $112.0 million during Q1 2021.
- Moreover, its 5-year median value for Goodwill was $25.6 billion (2025), whereas its average is $24.1 billion.
- In the last 5 years, Novartis Ag's Goodwill tumbled by 9558.01% in 2021 and then soared by 1981959.46% in 2023.
- Over the past 5 years, Novartis Ag's Goodwill (Quarter) stood at $29.6 billion in 2021, then decreased by 0.99% to $29.3 billion in 2022, then decreased by 20.34% to $23.3 billion in 2023, then grew by 6.06% to $24.8 billion in 2024, then increased by 3.28% to $25.6 billion in 2025.
- Its Goodwill was $25.6 billion in Q4 2025, compared to $25.6 billion in Q3 2025 and $25.6 billion in Q2 2025.